Thiorphan - Isotope Labelled Standards
References
FAQ's
References
- Roques, Bernard; Schwartz, Jean Charles; Lecomte, Jeanne Marie, Amino-acids derivatives and their therapeutic use, EP38758B1, Mar 6, 1985, Societe civile bioprojet 30, rue des Francs Bourgeois (https://worldwide.espacenet.com/patent/search/family/009240999/publication/EP0038758A1?q=EP0038758)
- Kuijpers, Eugenie A. P.; Den Hartigh, Jan; Vermeij, Pieter, A stability study involving HPLC analysis of aqueous thiorphan solutions in the presence of human serum albumin, Pharmaceutical Development and Technology, Volume: 3, Issue: 2, Pages: 185-192, 1998 DOI: (10.3109/10837459809028494)
Frequently Asked Questions
Why are Thiorphan Impurities necessary in pharmaceutical research?
Thiorphan Impurities are necessary for pharmaceutical research to determine drug safety.
How to control Thiorphan Impurities in a drug?
Thiorphan Impurities are controlled by evaluating the purity of starting materials and minimizing impurity formation during synthesis.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.